Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mylan Grabs More FDA Globalization Talent

This article was originally published in PharmAsia News

Executive Summary

Steve Lynn, director of CDER’s Office of Manufacturing and Product Quality, will take an executive global compliance position.

You may also be interested in...



FDA Searches Small Industry Candidate Pool To Fill Executive Vacancies

Criteria for FDA’s leadership vacancies are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying for the openings.

FDA Reorganization To Focus On Employee Specialization

Agency’s Program Alignment Group recommends “commodity-based and vertically-integrated programs” to improve efficiency and communication.

FDA’s Autor Moves To Mylan: Company’s Gain May Also Be Company’s Loss

While Mylan wants Autor to help push quality improvement efforts around the world, her departure from FDA may affect implementation of similar plans at the agency.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM013195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel